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Background: This study describes the prevalence, associated anomalies, and
demographic characteristics of cases of multiple congenital anomalies (MCA) in
19 population-based European registries (EUROCAT) covering 959,446 births
in 2004 and 2010. Methods: EUROCAT implemented a computer algorithm for
classification of congenital anomaly cases followed by manual review of potential
MCA cases by geneticists. MCA cases are defined as cases with two or more
major anomalies of different organ systems, excluding sequences, chromosomal
and monogenic syndromes. Results: The combination of an epidemiological
and clinical approach for classification of cases has improved the quality and
accuracy of the MCA data. Total prevalence of MCA cases was 15.8 per 10,000
births. Fetal deaths and termination of pregnancy were significantly more
frequent in MCA cases compared with isolated cases (p< 0.001) and MCA
cases were more frequently prenatally diagnosed (p< 0.001). Live born infants
with MCA were more often born preterm (p< 0.01) and with birth
weight< 2500 grams (p< 0.01). Respiratory and ear, face, and neck anomalies
were the most likely to occur with other anomalies (34% and 32%) and
congenital heart defects and limb anomalies were the least likely to occur with
other anomalies (13%) (p< 0.01). However, due to their high prevalence,
congenital heart defects were present in half of all MCA cases. Among males
with MCA, the frequency of genital anomalies was significantly greater than the
frequency of genital anomalies among females with MCA (p< 0.001).
Conclusion: Although rare, MCA cases are an important public health issue,
because of their severity. The EUROCAT database of MCA cases will allow
future investigation on the epidemiology of these conditions and related
clinical and diagnostic problems.
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Introduction
Congenital anomaly (CA) registries have been established
primarily to identify unexpected occurrence of CA which
may be due to possible teratogenic agents. After 30 years
of monitoring and surveillance only a few new teratogenic
agents have been identified. Population surveillance pro-
grams show that classifying CA according to presumed eti-
ology focuses further investigation of cases. Surveillance of
multiple congenital anomaly (MCA) cases is considered to
be more sensitive for detecting new teratogens than sur-
veillance of all or isolated CA cases because many known
human teratogens are associated with a spectrum of birth
defects rather than single defects (Khoury et al., 1987,
1993, 1994; Kalter, 1998; K€allen et al., 1999). Further-
more, the goal of case classification is to use knowledge of
embryologic and pathogenetic mechanisms to make case
groups used for analysis more comparable. However the
etiology of many CAs remain unknown and there are still
concerns about environmental causes (Khoury et al., 1994;
Opitz, 1994; Martinez-Frias et al., 1997, 2001; Zhu et al.,
2009). New areas of developmental biology have been
derived due to findings that external environmental agents
can alter normal gene expression patterns through DNA
methylation and other epigenetic mechanisms (Gilbert,
2004; Kubota, 2008; Martinez-Frias, 2010; Hales et al.,
2011). As imprinted genes have an important role in
growth and development, aberrant expression of
imprinted genes due to genetic or epigenetic abnormalities
is involved in the pathogenesis of human disorders, or
imprinting disorders. Beckwith-Wiedemann syndrome is a
representative imprinting disorder characterized by mac-
rosomia, macroglossia, and abdominal wall defects, and
exhibits a predisposition to tumorigenesis.
Many other unrecognized multiple anomalies may have
the same etiology. As MCA are quite rare, they also repre-
sent a diagnostic and management problem, especially
when counseling affected families (de Jong and Kirby,
2000).
The ability of congenital anomaly registries to identify
cases in a consistent and standardized manner is required
to allow epidemiological and etiological studies. Finally,
the completeness and accuracy of reporting of MCA cases
is relevant for monitoring defect combinations and specific
malformation patterns occurring among different catego-
ries of malformed cases.
For the present study, MCA cases are defined as cases
with two or more structural malformations that cannot be
explained by an underlying syndrome or sequence. Cases
were classified according to the computer algorithm devel-
oped by EUROCAT (Garne et al., 2011) which was based
on the International Classification of Disease version 10
(ICD-10) codes. The algorithm gives explicit coding rules
for classification and picks out a subset of potential MCA
cases to be manually checked by three geneticists. The aim
of this study is to show the application of the algorithm to
EUROCAT data (2004–2010) for surveillance of MCA in
Europe.
Materials and Methods
The study is based on routinely collected data for the
years 2004 and 2010 from 19 European registries of con-
genital anomalies, extracted from the EUROCAT central
database in November 2012. Data from 2004 were used
for developing the computer algorithm for classification of
cases (Garne et al., 2011). The year 2010 was the first
dataset to be reviewed as part of the routine surveillance
of MCA. Data for the years 2005 to 2009 have not yet
been reviewed in relation to MCA. The EUROCAT registries
are population based using multiple sources of informa-
tion including hospital records, birth and death certifi-
cates, and postmortem examinations, and include
information about live births, fetal deaths with gestational
age (GA) 20 weeks and termination of pregnancy after
prenatal diagnosis of fetal anomaly (TOPFA). All structural
malformations, syndromes and chromosomal anomalies
are included in the database except minor and poorly
specified anomalies as detailed on the exclusion list. Regis-
tries may or may not report minor anomalies to EUROCAT
central database. Cases with a false-positive prenatal diag-
nosis are not included in the database. Two registries
included cases diagnosed up to 1 week after birth and 17
registries included cases diagnosed up to at least 1 year of
age. A detailed description of registries, methods of case
ascertainment, data collection and processing is available
elsewhere (www.eurocat-network.eu/content/EUROCAT-
Guide-1.3.pdf), (Boyd et al., 2011; Greenlees et al., 2011).
The EUROCAT classification of congenital anomaly cases
is as follows (a case can belong to only one of these
groups): (a) Chromosomal syndromes: All cases where an
unbalanced chromosomal anomaly has been diagnosed,
irrespective of types of anatomically defined anomalies. (b)
Genetic and environmental syndromes: All cases due to a
single gene defect or a known environmental teratogen,
irrespective of types of anatomically defined anomalies. (c)
Isolated anomalies: All cases with one congenital anomaly/
anomalies occurring in only one organ subgroup or with a
known sequence where multiple congenital anomalies cas-
cade as a consequence of a single primary anomaly. (d)
MCA: Cases with two or more major congenital anomalies
in different organ systems, where the pattern of anomalies
has not been recognized as part of a syndrome or sequence.
The computer algorithm for classification of major con-
genital anomaly cases in the EUROCAT database was used
for case classification. The group classified as potential
MCA cases were manually reviewed by three geneticists to
reach the final agreement on classification. The computer
algorithm includes those sequences that can be coded by
specific ICD10 codes for the anomalies involved in the
sequence (step 21 in Appendix to Garne et al., 2011).
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Remaining sequences will be found during the manual
review and agreed by the geneticists.
All cases corresponding to the definition of MCA and
born in the year 2004 or 2010 with data available for both
years were included in the study. Nineteen EUROCAT regis-
tries met the study inclusion criteria. Epidemiological data
for cases classified as isolated congenital anomaly from the
same 19 registries in 2004 and 2010 was used for
comparison.
The variables included in the analysis were: birth out-
come, gender, maternal age at delivery, birth weight, GA at
birth or termination, time of diagnosis (pre- or postnatal)
and type of the congenital anomalies (ICD10 code and
written text). All variables included in this study were
EUROCAT core variables. The variables are defined in the
EUROCAT Guide 1.3 available at the EUROCAT Web site.
Prenatal diagnosis is defined as the first suspicion of a
major congenital anomaly in a live fetus at any GA.
Statistics: Descriptive statistics and chi square tests
were performed using STATA version 12.1 (StataCorp LP,
College Station, TX).
Results
A total of 24,255 cases with congenital anomalies among
959,446 births were reported for the years 2004 and
2010 giving an overall prevalence of congenital anomalies
of 253 per 10,000 births in the 19 registries. Over the
same period 1,517 MCA cases were identified with a prev-
alence of 15.8 per 10,000 (Table 1). The prevalence of all
anomalies decreased from 2004 to 2010 (p< 0.001); how-
ever, the prevalence of multiple anomalies remained fairly
constant (p5 0.10). Of the 1,517 MCA cases 1,096
(72.3%) were live births, 49 (3.2%) were fetal deaths and
372 (24.5%) were TOPFA. Fetal death and TOPFA were
significantly more frequent in MCA compared with isolated
congenital anomalies (p< 0.001; Table 2).
MCA cases were more likely to be diagnosed prenatally
than isolated cases (54.8% compared with 31.0%,
p< 0.001) (Table 3). Few MCA cases were diagnosed after
1 month of age. The proportion of MCA cases diagnosed
prenatally increased significantly between the years 2004
and 2010 (p< 0.05).There were large differences in prena-
tal detection rate by registry (range, 31–79%), but there
was no association between the prenatal detection rate
and the prevalence of MCA by registry.
Among the MCA cases there were 826 males (54.4%)
and 601 females (39.6%; Table 4). The gender distribution
was the same as for isolated CA (p> 0.05). A total of 345
of 1096 live births (31.5%) were born with a GA< 37
weeks compared with 2290 of 15,025 (15.2%) isolated
cases (p< 0.01) and 321 (29.3%) were born with a birth
weight less than 2500 grams compared with 12.92% of
isolated cases (p< 0.01). Of the 19 registries that partici-
pated in the study, 16 provided data on chromosomal
analysis. A karyotype analysis was carried out in 59.0% of
the MCA cases in these 16 registries (418/709). A post-
mortem examination was performed in 83.9% of MCA
cases resulting in TOPFA.
The 1517 MCA cases presented with approximately
5000 anomalies and the number of anomalies per case
showed a tendency to increase depending on the outcome:
TABLE 1. Prevalence of Congenital Anomalies and Multiple Congenital Anomalies Reported to 19 EUROCAT Registries in 2004 and 2010
Year Total births
Total congenital
anomaly cases
Prevalence
%
Prevalence
2004 vs 2010
Total multiple congenital
anomaly cases
Prevalence per
10,000 births
Prevalence
2004 vs 2010
2004 445 838 12 410 2.78 p< 0.001 673 15.1 p5 0.10
2010 513 608 11 845 2.31 844 16.5
Total 959 446 24 255 2.53 1517 15.8
TABLE 2. Comparison between Outcomes of Pregnancies with Multiple Congenital Anomalies and Isolated Congenital Anomalies, 19 EUROCAT Registries in 2004
and 2010
Multiple congenital anomaliesa Isolated congenital anomaliesa
Year Live births (%) Fetal deaths (%) TOPFAb (%) Live births (%) Fetal deaths (%) TOPFAb (%)
2004 491 (73.0) 23 (3.4) 159 (23.6) 7510 (89.4) 115 (1.4) 772 (9.2)
2010 605 (71.7) 26 (3.1) 213 (25.2) 7515 (89.5) 114 (1.4) 765 (9.1)
Total 1096 (72.2) 49 (3.2) 372 (24.5) 15025 (89.5) 229 (1.4) 1537 (9.2)
aThe outcomes for multiple congenital anomalies were significantly different from those for isolated congenital anomalies (p<0.001). The out-
comes were similar for 2004 and 2010 (p>0.8).
bTOPFA, termination of pregnancy for fetal anomaly.
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live birth, fetal death or TOPFA. The most common anoma-
lies among the 1517 MCA cases were congenital heart
defects (CHD) (767) followed by congenital limb anomalies
(443), congenital renal anomalies (438), and congenital
anomalies of the digestive system (428). Of the 767 cases
with a CHD, 216 (28%) had ventricular septal defect as the
only cardiac anomaly and 141 (18%) had atrial septal defect
as the only cardiac defect. Important differences in organ
type are seen between isolated congenital anomalies and
MCA cases (Table 5; p< 0.001). Respiratory and ear, face,
and neck anomalies are the most likely to occur with other
anomalies (34% and 32% occurred with other anomalies)
and CHD, limb, and genital were the least likely to occur
with other anomalies (12–13%). However, due to the high
frequency of CHD, they were present in half of all MCA.
There was a highly significant difference in the proportion
of genital anomalies involved in MCA for male and females
(Fig. 1; p< 0.001). For limb defects, the gender difference
TABLE 3. Time of Diagnosis of Multiple Congenital Anomaly Cases and Isolated Congenital Anomaly Cases in 19 EUROCAT Registries in 2004 and 2010
Multiple congenital anomalies Isolated congenital anomalies
When diagnosed
Year 2004 Year 2010
Total (%) Total (%)N % N %
Prenatal diagnosis 341 50.7%a 491 58.2%a 832 (54.8%)b 5,197 (31.0%)b
At birth 231 34.3% 258 30.6% 489 (32.2%) 7,331 (43.7%)
Less 1 week after birth 27 4.0% 22 2.6% 49 (3.2%) 1,209 (7.2%)
1–4 weeks after births 7 1.0% 12 1.4% 19 (1.3%) 281 (1.7%)
1 month – 1 year after birth 10 1.5% 9 1.1% 19 (1.3%) 911 (5.4%)
After 1 year 2 0.3% 1 0.1% 3 (0.2%) 111 (0.7%)
At spontaneous abortion 1 0.1% 1 0.1% 2 (0.1%) 8 (0.1%)
At post mortem 4 0.6% 0 0.0% 4 (0.3%) 13 (0.1%)
Postnatal, time not known - 12 1.4% 12 (0.8%) 341 (2.0%)
Not known 50 7.4% 38 4.5% 88 (5.8%) 1,389 (8.3%)
Total cases 673 844 1517 16,791
aThe proportion of multiple congenital anomaly cases diagnosed prenatally was significantly higher in 2010 compared with 2004 (p<0.05).
bThe proportion of multiple congenital anomaly cases diagnosed prenatal was significantly higher than for isolated anomalies (p<0.001).
TABLE 4. Characteristics of Multiple Congenital Anomaly Cases and Isolated Congenital Anomaly Cases in 19 EUROCAT Registries in 2004 and 2010
Characteristics
Number of multiple congenital
anomaly cases (n51,517)
Number of Isolated congenital
anomaly cases (n516,791)
Gender
Male 826 (54%) 9484 (56%) Non significant
Female 601 (40%) 6716 (40%)
Indeterminate sex 6 (< 1%) 15 (<1%)
Unknown 84 (6%) 576 (3%)
Gestational age at live birth – gender known 1095 live births 14993 live births
< 37 345 (32%) 2290 (15%) p< 0.01
37–41 707 (65%) 11634 (78%)
 42 15 (1%) 440 (3%)
Unknown 28 (3%) 629 (4%)
Gestational age at prenatal diagnosis (mean, SD) (range) 20.7 (6.0) (10–41) 21.9 (6.4) (5–42) p< 0.01
Gestational age at TOPFA (mean, range) 19.5 (4.2) (11–35) 18.9 (4.6) (10–38) p< 0.05
Mean maternal age at birth 29.6 29.5 Non significant
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was also significant (p< 0.001), but there was no significant
gender difference for the other organ systems.
Discussion
Surveillance of MCA cases is considered to be more sensi-
tive for the detection of new teratogens than surveillance of
all or isolated congenital anomalies. The current literature
proposes the manual review of all cases for classification
but this can lack uniformity. By implementing a computer
algorithm for the classification of cases and the manual
review only of potential MCA cases by an expert panel of
geneticists, EUROCAT has established a feasible, efficient,
and transparent way to monitor MCA cases for surveillance
and research. The combination of this epidemiological and
clinical approach to the classification of cases has improved
the quality and accuracy of data that can be used for fur-
ther investigation of a large series of MCA patients.
The use of different methodologies and different case
classification systems impacts on the estimated prevalence
of MCA cases. The available prevalence data on MCA cases
in the literature range from 10.9 per 10,000 births (ICBD
– EUROCAT 1998) to 16.3 per 10,000 births (Martinez-
Frias et al., 1990), and 26 per 10,000 births (Czeizel et al.,
1988). The EUROCAT study found a prevalence of 15.8 per
10,000 births. This prevalence remained stable (15.1 per
10,000 in 2004 and 16.5 in 2010), and is in agreement
with other large population studies (Khoury et al., 1991)
making it a possible reference point for future epidemio-
logical studies.
Changes over time in prenatal and postnatal diagnostic
methods may also impact on the prevalence of MCA cases.
The increasing use of first trimester ultrasound scan may
diagnose severe MCA cases as anencephaly or large
abdominal wall defects resulting in an early TOPFA with-
out recognition of additional anomalies. Most MCA cases
were diagnosed prenatally, but still 40% of them remained
undiagnosed until birth. The TOPFA rate of MCA cases
remained constant from 2004 to 2010, despite a signifi-
cant increase in the prenatal detection rate. This may be
explained by an increased detection of less severe anoma-
lies as cleft lip, club foot and hydronephrosis. For these
anomalies the TOPFA rate will continue to be low unless
associated with other more severe anomalies. The
FIGURE 1. Multiple congenital anomalies by organ system as a proportion of
multiple and isolated congenital anomalies for males and females in 19
EUROCAT registries in 2004 and 2010. Black bars are 95% confidence
intervals.
TABLE 5. Number and Frequency of Anomalies by Organ System in Multiple Congenital Anomalies and Isolated Congenital Anomalies in 19 EUROCAT Registries
in 2004 and 2010
EUROCAT organ
system Subgroups
Multiple congenital
anomalies
Isolated congenital
anomalies
Multiple congenital anomalies as a
proportion of Isolated & multiple
congenital anomalies (95% CI)
Cases 1,517 (100%) 16,791 (100%)
Organ system
Respiratory 172 (11.3%) 333 (2.0%) 34% (30%–38%)
Ear, face, and neck 62 (4%) 132 (0.8%) 32% (25%–39%)
Eye 101 (6.6%) 238 (1.4%) 30% (25%–35%)
Digestive system 428 (28.2%) 1038 (6.2%) 29% (27%–32%)
Nervous system 428 (28%) 1,553 (9.3%) 22% (20%–23%)
Abdominal wall defects 99 (6.5%) 451 (2.7%) 18% (15%–21%)
Renal 438 (28.9%) 2,233 (13.3%) 16% (15%–18%)
Oro-facial clefts 203 (13.4%) 1068 (6.4%) 16% (14%–18%)
Congenital heart defects 767 (50.6%) 5,091 (30.3%) 13% (12%–14%)
Limb 443 (29.2%) 3,071 (18.3%) 13% (12%–14%)
Genital 226 (14.9%) 1,630 (9.7%) 12% (11%–14%)
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differences in prenatal detection rates between countries
are well known and have been reported to be related to
different prenatal screening policies (Boyd et al., 2008;
Garne et al., 2010). This represents a challenge for the
future surveillance of MCA cases, and monitoring of prena-
tal diagnosis of MCA cases may be used as a public health
indicator of the effectiveness of prenatal diagnostic serv-
ices. Increasing use of second trimester ultrasound screen-
ing and postnatal ultrasound examinations may diagnose
congenital anomalies that may have been undiagnosed in
earlier time periods (for example, hydronephrosis, atrial
septal defect, or ventricular septal defect) and thereby
increase the prevalence of MCA cases.
As postmortem examination is difficult at early GA,
associated congenital anomalies in the fetus may be undiag-
nosed. Also use of array technique and DNA diagnostics
may lead to a future decrease in the prevalence of MCA, as
more cases will be diagnosed as genetic syndromes.
The outcome of pregnancy was significantly different
for MCA cases compared with the outcome for isolated CA
cases in the same time period, with a significantly higher
prevalence of TOPFA and fetal deaths, indicating the seri-
ousness of the condition. No differences were found for
the sex ratio between MCA and isolated cases, whilst ges-
tational age and birth weight were significantly lower for
live births with MCAs.
The comparison of organ systems involved in MCA
cases found that the organ system with the highest preva-
lence in general (CHD) was less likely to be involved in
MCA cases (13% of CHD cases were part of MCA). How-
ever, congenital heart defects were included in half of all
MCA cases because of the high prevalence in general. Eye
anomalies and anomalies of ear, face, and neck were asso-
ciated with MCA cases for almost one-third of the cases.
There may have been some bias in the reporting to EURO-
CAT for these anomalies as part of an MCA case and they
may be less likely to be reported as isolated congenital
anomalies. The knowledge of the risk of associated major
anomalies is important after a prenatal or neonatal diag-
nosis of an anomaly in one organ system.
MCA are an important subgroup of rare diseases with
implications for public health, including the burden of
their management, and the psychological and emotional
implications for families (Rosenthal et al., 2001).
Epigenetics was defined by Waddington (1940) as
“. . . the interactions of genes with their environment which
bring the phenotype into being”, and refers to heritable
modifications of gene expression and cell phenotype in
absence of alterations to the DNA sequence. The epigenetic
control mechanism is responsible for multiple cell signal-
ing events and may be vulnerable to deregulation by envi-
ronmental factors. Epigenetic processes are required
throughout development and modification of an epigenetic
state has the capacity to create a new phenotype.
Beckwith-Wiedemann syndrome is a representative
imprinting disorder characterized by macrosomia, macro-
glossia, and abdominal wall defects, and exhibits a predis-
position to tumorigenesis. Many other unrecognized
multiple anomalies may have the same etiology, as epige-
netics can be modified by environmental factors through
molecular mechanisms derived from the environment to
alter genomic activity and developmental biology. Epige-
netics studies may help to establish the molecular basis of
gene-environment interactions.
The major strengths of this study are the large number of
births that have been evaluated, that it is population-based
and that participating registries use the same epidemiologi-
cal methods. Cases were actively ascertained through multi-
ple data sources from geographically defined residential
populations. The same definitions and coding system for the
CA were used by all participants. A standardized algorithm
for the evaluation of multiples using software and manual
evaluation by genetic experts was used to determine preva-
lence and other characteristics of MCA cases, and can be
used for further studies. In interpreting these results, the
limitations and strengths of the study should be taken into
consideration. The main limitation of our data is that not all
MCA cases had a known cytogenetic result. Consequently, it
is possible that some MCA cases would ultimately be reclas-
sified as chromosomal. With the advances in cytogenetics
and molecular genetics, it is expected that this type of reclas-
sification of MCA cases into chromosomal or syndrome cate-
gory will continue. Other potential limitations are that local
registries may not code congenital anomalies according to
the EUROCAT coding instructions and data on the postmor-
tem results may be inadequate.
CONCLUSIONS
MCA cases are an important subgroup of rare diseases with
implications for public health, due to the severity and the
burden related to their management. This study provides
further epidemiologic data on MCA cases using the EURO-
CAT algorithm comparing cases from two time periods. The
prevalence of MCA cases seems stable, but further monitor-
ing is needed. By creating a standardized database of MCA
cases across Europe, it may be possible to conduct statisti-
cal surveillance of MCA looking for new teratogens and to
investigate the possible role of epigenetics in the occur-
rence of complex developmental disorders.
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